ARDELYX INC. - COMMON STOCK

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025

21 May 2025 05:00:03 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: ARDELYX INC. - COMMON STOCK

15 May 2025 07:30:35 By NetDania Notify

NetDania - New 12 months Low: ARDELYX INC. - COMMON STOCK

14 May 2025 06:50:47 By NetDania Notify

NetDania - New 12 months Low: ARDELYX INC. - COMMON STOCK

13 May 2025 06:48:50 By NetDania Notify

NetDania - New 12 months Low: ARDELYX INC. - COMMON STOCK

08 May 2025 06:48:11 By NetDania Notify

Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference

06 May 2025 05:01:45 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: ARDELYX INC. - COMMON STOCK

05 May 2025 06:55:51 By NetDania Notify

Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update

01 May 2025 13:01:51 By Nasdaq GlobeNewswire

Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

29 Apr 2025 05:00:02 By Nasdaq GlobeNewswire

Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference

24 Apr 2025 05:01:45 By Nasdaq GlobeNewswire

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025

17 Apr 2025 05:00:56 By Nasdaq GlobeNewswire

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings

10 Apr 2025 13:02:47 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: ARDELYX INC. - COMMON STOCK

09 Apr 2025 08:09:12 By NetDania Notify

NetDania - New 12 months Low: ARDELYX INC. - COMMON STOCK

07 Apr 2025 06:47:21 By NetDania Notify

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings

31 Mar 2025 13:03:51 By Nasdaq GlobeNewswire

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award

13 Mar 2025 05:02:40 By Nasdaq GlobeNewswire

Tenapanor Approved in China for Hyperphosphatemia

26 Feb 2025 04:00:38 By Nasdaq GlobeNewswire

Ardelyx to Participate in Upcoming Investor Conferences

25 Feb 2025 13:15:00 By Nasdaq GlobeNewswire

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

20 Feb 2025 04:30:54 By Nasdaq GlobeNewswire

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

19 Feb 2025 05:01:00 By Nasdaq GlobeNewswire